Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Benefits of ranolazine treatment seen in MERLIN-TIMI 36 trial

Nov. 21, 2007

Studies describe novel non-nucleoside HCV RNA polymerase inhibitor GS-9190

Nov. 21, 2007

Small peptide inhibitor of PKC gamma shows activity in neuropathic pain models

Nov. 21, 2007

KCNQ2/3 channel opener from ICAgen shows activity in pain in vivo models

Nov. 21, 2007

Taisho reports on novel antagonists of the MCH receptor 1

Nov. 20, 2007

Pharmacological interventions for hepatic pathologies discussed at Liver Meeting

Nov. 20, 2007

A TGF-beta inhibitor protects against radiation-induced lung damage

Nov. 20, 2007

Vasohibin beneficial in early diabetic nephropathy model

Nov. 20, 2007

Primate studies elucidate activity of novel small-molecule, cholesterol-lowering agents

Nov. 20, 2007

Novel small-molecule compound appears to extend L-DOPA antiparkinsonian effects

Nov. 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...